Patents by Inventor Skylar J. FERRARA

Skylar J. FERRARA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amide prodrugs of small molecule nuclear receptor modulators
    Patent number: 11613517
    Abstract: Provided herein are novel amide prodrug forms of pharmaceutically active agents useful for central nervous system disorders.
    Type: Grant
    Filed: February 26, 2019
    Date of Patent: March 28, 2023
    Assignee: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas S. Scanlan, Skylar J. Ferrara
  • Amide compounds, pharmaceutical compositions thereof, and methods of using the same
    Patent number: 11325886
    Abstract: Amide compounds are disclosed. Also disclosed are pharmaceutical compositions comprising the compounds as well as methods of treating neurodegenerative diseases that involve administering the compounds or pharmaceutical compositions to a subject.
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: May 10, 2022
    Assignee: Oregon Health & Science University
    Inventors: Thomas S. Scanlan, James Matthew Meinig, Skylar J. Ferrara, Tapasree Banerji, Tania Banerji
  • AMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
    Publication number: 20210284599
    Abstract: Amide compounds are disclosed. Also disclosed are pharmaceutical compositions comprising the compounds as well as methods of treating neurodegenerative diseases that involve administering the compounds or pharmaceutical compositions to a subject.
    Type: Application
    Filed: August 14, 2017
    Publication date: September 16, 2021
    Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas S. SCANLAN, James Matthew MEINIG, Skylar J. FERRARA, Tapasree BANERJI, Tania BANERJI
  • AMIDE PRODRUGS OF SMALL MOLECULE NUCLEAR RECEPTOR MODULATORS
    Publication number: 20210087137
    Abstract: Provided herein are novel amide prodrug forms of pharmaceutically active agents useful for central nervous system disorders.
    Type: Application
    Filed: February 26, 2019
    Publication date: March 25, 2021
    Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas S. SCANLAN, Skylar J. FERRARA